Home NVAX
16.52
  Price1.96%   -0.33
 
loading

Novavax, Inc. (NVAX) Latest News

Nov-30-22 10:20AM Novavax (NVAX) COVID Jab Gets Expanded Label in WHO's EULZacks Investment Research
08:50AM Do Options Traders Know Something About Novavax (NVAX) Stock We Don't?Zacks Investment Research
Nov-29-22 11:21AM IMF head joins chorus calling on China to adapt COVID strategy as officials pledge to boost vaccinations among elderlyMarketWatch
10:28AM IMF head joins chorus calling on China to adapt COVID strategy as officials pledge to boost vaccinations among elderlyMarketWatch
Nov-28-22 12:30PM Novavax (NVAX) Stock Nosedives 88% This Year: Here's WhyZacks Investment Research
Nov-26-22 10:37AM Is Novavax Stock a Buy Now?The Motley Fool
05:30AM 3 Potentially Explosive Stocks to Buy Before 2023The Motley Fool
Nov-25-22 09:00AM Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to KnowZacks Investment Research
Nov-24-22 06:00AM Novavax Stock: Buy, Sell, or Hold in 2023?The Motley Fool
Nov-23-22 12:35PM Novavax (NVAX) Cancels COVID Jab Supply Deal With GAVIZacks Investment Research
02:48AM Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From TuesdayBenzinga
Nov-22-22 03:46AM Why Shares of Novavax Are Down TuesdayThe Motley Fool
09:00AM Jack Ma's Ant Group Slapped With $1B Fine, Carl Icahn's Huge Short Position In GameStop, Novavax Culls COVID-19 Vaccine Alliance With GAVI: Top Stories Tuesday, Nov. 22Benzinga
Nov-22-22 05:21AM Nasdaq Bear Market: 3 Remarkable Growth Stocks Down Over 90% That Can Double Your Money by 2025The Motley Fool
Nov-15-22 06:25AM 2 Cheap Stocks to Buy Right NowThe Motley Fool
Nov-14-22 09:00AM Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should KnowZacks Investment Research
Nov-13-22 05:21AM Here Are All 23 Stocks I've Bought During the 2022 Bear MarketThe Motley Fool
Nov-10-22 08:19AM Manufacturing hub Guangzhou is latest Chinese city to face lockdowns as COVID cases riseMarketWatch
05:06AM Nasdaq Bear Market: 3 Phenomenal Bargains That Can Double Your Money by 2027The Motley Fool
Nov-09-22 02:01AM Dow skids 550 points as investors brace for inflation update, monitor midterm resultsMarketWatch
01:35AM Dow skids 400 points and stocks fall as control of Congress remains unsettledMarketWatch
Nov-09-22 01:12AM Manufacturing hub Guangzhou is latest Chinese city to face lockdowns as COVID cases riseMarketWatch
12:04PM Dow falls 250 points and stocks slip as control of Congress remains unsettledMarketWatch
Nov-09-22 11:26AM Manufacturing hub Guangzhou is latest Chinese city to face lockdowns as COVID cases riseMarketWatch
11:17AM U.S. stocks slip as control of Congress remains unsettledMarketWatch
Nov-09-22 10:46AM Novavax (NVAX) Q3 Earnings Miss, Lowers '22 Sales OutlookZacks Investment Research
10:31AM Manufacturing hub Guangzhou is latest Chinese city to face lockdowns as COVID cases riseMarketWatch
Nov-09-22 08:09AM Novavax stock rallies, even as company offers a dimmer sales forecast for vaccinesMarketWatch
Nov-08-22 01:11AM China sees violent protests against COVID restrictions, and U.S. cases have been risingMarketWatch
Nov-01-22 03:19AM Biotech And XBI: The Bottom Is InSeeking Alpha
Oct-31-22 10:00AM Earnings Preview: Qiagen (QGEN) Q3 Earnings Expected to DeclineZacks Investment Research
Oct-28-22 09:00AM Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research
Oct-27-22 10:03AM Novavax (NVAX) to Report Q3 Results: Wall Street Expects Earnings GrowthZacks Investment Research
09:53AM Could This Bullish News Make Novavax a Hot Buy?The Motley Fool
Oct-25-22 04:36AM Avis Budget, Scholastic And Other Big Gainers From MondayBenzinga
Oct-24-22 07:14AM CDC shoots down false claims it will mandate COVID-19 vaccines for schoolchildren, saying states make that decisionMarketWatch
07:07AM Novavax (NVAX) to Report Q3 Earnings: What's in the Cards?Zacks Investment Research
Oct-24-22 05:37AM Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From FridayBenzinga
04:19AM Moderna, Amazon, Tesla, And Other Big Gainers From FridayBenzinga
Oct-22-22 10:01AM Pfizer sets new prices for its COVID-19 vaccines. The cost? $110 to $130 per doseMarketWatch
Oct-21-22 06:44AM Why Novavax Stock Rose 12.57% on FridayThe Motley Fool
01:35AM Why Boston Beer Shares Are Trading Higher? Here Are 52 Stocks Moving In Friday's Mid-Day SessionBenzinga
Oct-21-22 11:03AM CDC shoots down false claims it will mandate COVID-19 vaccines for schoolchildren, saying states make that decisionMarketWatch
09:35AM Company News for Oct 21, 2022Zacks Investment Research
Oct-21-22 09:16AM Pfizer sets new prices for its COVID-19 vaccines. The cost? $110 to $130 per doseMarketWatch
08:22AM Jim Cramer Says This Stock 'Down Here At This Level Is A Terrific Buy'Benzinga
Oct-20-22 01:13AM Novavax (NVAX) Receives FDA Nod for COVID-19 Booster JabZacks Investment Research
12:28PM WHO says another omicron subvariant, which may be more resistant to antibodies, spread to 26 countries in latest weekMarketWatch
Oct-20-22 11:28AM Biotech Stock Roundup: NERV, RLMD Down on Updates, MRNA, NVAX's News & MoreZacks Investment Research
09:37AM Is It Too Late to Buy Novavax Stock?The Motley Fool
Novavax, Inc., together with its subsidiary, Novavax AB, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of recombinant nanoparticle vaccines and adjuvants. Its lead adjuvant is Matrix-M that is used to enable a vaccine to enhance the amplitude of the immune response and qualitatively change it, enhance its specificity to provide protection against related microorganisms, as well as allows immunization with much lower doses of antigen. The company develops respiratory syncytial (RSV) virus fusion protein nanoparticle vaccine candidate for infants via maternal immunization in Phase III clinical trial; older adults in Phase II clinical trial; and children six months to five years of age in Phase I clinical trial. Novavax, Inc. also develops NanoFlu vaccine, which is in Phase I/II clinical trial for treating seasonal influenza in older adults; and Ebola virus glycoprotein vaccine that is in Phase I clinical trial. Its preclinical programs include Zika virus; combination respiratory vaccine candidate to protect against RSV and seasonal influenza, as well as other infectious disease vaccine candidates. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.
Cap:    |  Volume (24h):